Dabur India

B+Hold

DABUR · NSE · Large Cap · FMCG Supplier

FMCG Supplier

Fetching live…

₹510

1D -0.1%1M -1.0%1Y -8%

Fundamental (RQ-100)

Technical (TQ-100)

Valuation

Market cap

₹92.0K Cr

Live decision ratingB+Sell / Avoid

Fundamental score breakdown

74/100

Growth Quality

7.4 / 20

Rev 1Y 4.0%, 3Y CAGR 8.0%, 5Y CAGR 8.0%

Margin & Profitability

12.0 / 15

EBITDA 20.0%, PAT 14.0%

Return on Capital

16.0 / 20

ROCE 22.0%, ROE 18.0%

Cash Flow Quality

13.0 / 15

OCF/EBITDA 0.85

Leverage

10.0 / 10

ND/EBITDA -0.50

Reinvestment

5.0 / 8

Capex/Sales 2.0%

Accounting

7.0 / 7

Governance

4.0 / 5

Technical score breakdown

40/100

Trend Structure

8.0 / 20

↓ 200 · ↓ 50 · ↓ 20

Momentum

5.0 / 15

1Y -8.0%, 1M -1.0%

Volume Dynamics

8.0 / 15

Vol30 —%

Relative Strength

4.0 / 15

1Y -8.0%

MA Cluster

5.0 / 10

Extension

5.0 / 10

—% from 50DMA

Volatility

4.0 / 8

Price Action

1.0 / 7

-100.0% from 52W H

Business

What this company actually does

Ayurvedic + healthcare + foods (Real, Vatika).

Stores

—

Dark stores

—

Cities

—

Listed status

Listed

Format exposure

How direct is this play?

Primary formatFMCG Supplier

Exposure typeMeaningful

Revenue visibilityHigh

Operating leverage stageMaturity

Policy beneficiaryNone

Data confidenceMedium

Financial snapshot

Live · green dot = live, falls back to curated

Revenue

₹12.5K Cr

Rev 1Y growth

Rev 3Y CAGR

EBITDA margin

20.0%

PAT margin

14.0%

ROE

18%

ROCE

22%

OCF/EBITDA

0.85

Net Debt/EBITDA

-0.5

Financial statements

Multi-year P&L, balance sheet, cash flow — scraped live from Screener.in

Fetching from Screener.in…

Loading…

Valuation

Live multiples + retail-specific (curated)

P/E

Forward P/E

EV/EBITDA

EV/Sales

7.5

P/B

8.0

FCF Yield

1.6%

Mid-range valuation. Watch incremental ROCE.

Investment thesis

AI-generated · always cite sources before acting

Bull

Best-in-class 22% ROCE with 0.85 OCF conversion. Long-runway TAM with structural tailwinds.

Base

Earnings growth of ~9% over the next 3 years assuming margins hold. Multiple compression risk if growth slows; multiple expansion possible if FMCG Supplier GMV outperforms.

Bear

Format-level risk: regulation, gig-cess, or competitive pressure compress contribution margin.

Variant perception

Consensus views Dabur India as a decent operator. Our differentiated take: the current multiple already prices in mid-cycle outcomes.

Key monitorables

Quarterly EBITDA margin trajectory
Revenue growth vs management guidance
Capex vs store/dark-store adds
Promoter holding and ESOP dilution

Peers

Same primary format · sorted by market cap